Dana Goldman, PhD

Executive Director of the USC Leonard D. Schaeffer Institute for Public Policy & Government Service and Special Advisor to the Provost

Image of Dana Goldman, PhD
Is this your profile? Click to edit

Overview

Dana Goldman is a Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics. Until Fall 2009, he held RAND’s Distinguished Chair in Health Economics and directed RAND’s program in Economics, Finance, and Organization. He is also an Adjunct Professor of Health Services and Radiology at UCLA.

Dr. Goldman is a nationally-recognized health economist influential in both academic and policy circles. He is the author of over 100 articles and book chapters, including articles in some of the most prestigious medical, economic, health policy, and statistics journals. He is a health policy advisor to the Congressional Budget Office, and is a frequent speaker on health care issues. He serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is also a founding editor of the Forum for Health Economics and Policy, an online journal devoted to health economics and health policy.

Dr. Goldman’s work has been featured in the New York Times, Wall Street Journal, Washington Post, Business Week, U.S. News and World Report, The Economist, NBC Nightly News, CNN, National Public Radio, and other media. Dr. Goldman was the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy. He was awarded the National Institute for Health Care Management Research Foundation award for excellence in health policy, and the Alice S. Hersh New Investigator Award recognizing the contributions of a young scholar to the field of health services research. He also has served on several panels for the National Academy of Sciences and Institute of Medicine, including a current panel on the fiscal future of the United States.

Dr. Goldman’s research sponsors include the National Institutes of Health, National Institute on Aging, National Cancer Institute, National Science Foundation, Amgen, Merck, Genentech, Pfizer, UnitedHealth, Pacificare, California Healthcare Foundation, Smith Richardson Foundation, Department of Defense, Department of Labor, and the Agency for Healthcare Research and Quality.

Dr. Goldman is also a research associate with the National Bureau of Economic Research, the nation’s leading economic research organization. He is the director of the RAND/UCLA Health Services Research Postdoctoral Training Program. He is also a founder and managing director of Precision Health Economics, a consulting firm to the health care industry. Dr. Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.

Research Funding

  • The United States Cost of Dementia Model: Quantifying Current and Future Impacts of Alzheimer?s Disease and Related Dementias
    NIH · U01AG086827 · Jun 1, 2024 – Mar 31, 2029 · Role: Co-Principal Investigator
  • Microsimulation to Improve the Health and Wellbeing of Older Populations
    NIH · R13AG069518 · Sep 1, 2020 – Aug 31, 2021 · Role: Principal Investigator
  • Center for Advancing Sociodemographic and Economic Study of Alzheimer's Disease and Related Dementias (CeASES-ADRD)
    NIH · P30AG066589 · Jul 16, 2020 – Aug 31, 2027 · Role: Co-Principal Investigator
  • Precision Medicine: Moving Theory into Practice
    NIH · R13HS026821 · Jul 9, 2019 – Jun 30, 2021 · Role: Principal Investigator
  • Ensuring Access to Novel Alzheimer?s and Dementia Treatments: Evaluating Innovative Payment Approaches
    NIH · R01AG062277 · Sep 30, 2018 – May 31, 2022 · Role: Principal Investigator
  • Understanding and Modeling Innovation in Alzheimer?s Disease
    NIH · R56AG052949 · Sep 30, 2016 – Aug 31, 2018 · Role: Principal Investigator
  • The Long-Term Benefits of Interventions to Improve T2D Outcomes
    NIH · R01DK107552 · Jul 22, 2016 – Jun 30, 2021 · Role: Principal Investigator
  • One year day-and-night home closed loop in young people with type 1 diabetes
    NIH · UC4DK108520 · Sep 30, 2015 – Sep 29, 2019 · Role: Co-Principal Investigator
  • Technological Innovation in Health Care and the Long-Term Fiscal Outlook
    NIH · R56AG045135 · Sep 15, 2014 – Jun 30, 2016 · Role: Principal Investigator
  • Transforming Research and Clinical Knowledge in Traumatic Brain Injury
    NIH · U01NS086090 · Sep 30, 2013 – Aug 31, 2020 · Role: Co-Principal Investigator
  • University of Southern California Resource Center for Aging and Dementia Research (USC RCAD)
    NIH · P30AG043073 · Sep 1, 2012 – Jun 30, 2028 · Role: Principal Investigator
  • AN ECONOMIC AND BEHAVIORAL EVALUATION OF MEDICARE PART D
    NIH · P01AG033559 · Sep 15, 2011 – Aug 31, 2016 · Role: Principal Investigator
  • The Science of Medicare Reform
    NIH · RC4AG039036 · Sep 30, 2010 – Aug 31, 2013 · Role: Co-Principal Investigator
  • ECONOMICS OF TREATING VIRAL STIs
    NIH · R01HD054877 · Sep 30, 2009 – Aug 31, 2012 · Role: Principal Investigator
  • Private Insurance and Prescription Outcomes for Children
    NIH · R03HD058203 · Jun 1, 2009 – May 31, 2012 · Role: Principal Investigator
  • Improving Pharmacy Benefit Design
    NIH · R01AG029514 · Sep 1, 2008 – Jul 31, 2013 · Role: Principal Investigator
  • Obesity Among Older Americans
    NIH · R01AG025743 · Jun 15, 2006 – May 31, 2012 · Role: Principal Investigator
  • USC-Yale Roybal Center for Behavioral Interventions in Aging
    NIH · P30AG024968 · Sep 30, 2004 – May 31, 2029 · Role: Principal Investigator
  • AN INVESTIGATION OF THE VIATICAL SETTLEMENTS MARKET
    NIH · R01AG022351 · Sep 15, 2003 – Aug 31, 2007 · Role: Principal Investigator
  • State and Federal Policy and Outcomes for HIV+ Adults
    NIH · R01HS010846 · Sep 30, 2001 – Apr 30, 2005 · Role: Principal Investigator
  • RAND MiniMedical School for Social Scientists
    NIH · R13AG018327 · Sep 15, 2000 – Dec 31, 2023 · Role: Co-Principal Investigator
  • HMO COST PERFORMANCE: A SIMULTANEOUS EQUATIONS APPROACH
    NIH · R03HS007490 · Sep 1, 1992 – Aug 31, 1994 · Role: Principal Investigator

Publications

  • Insulin Costs and Use by Medicare Beneficiaries After the Inflation Reduction Act Out-of-Pocket Cap. JAMA. 2026 07 07; 336(1):25-34.. View in PubMed
  • Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies. Am J Manag Care. 2026 07; 32(7):392-395.. View in PubMed
  • Scoring Health Reform-Congress Needs a Wider Aperture and Longer Exposure. JAMA Health Forum. 2026 Jun 01; 7(6):e261542.. View in PubMed
  • The cost of dementia in the United States in 2026. Alzheimers Dement. 2026 Jun; 22(6):e71480.. View in PubMed
  • A dynamic microsimulation method for estimating dementia costs in the United States. Alzheimers Dement. 2026 Jun; 22(6):e71549.. View in PubMed
  • Evaluating evidence-based recruitment strategies for Alzheimer’s disease and related dementias clinical trial research: A literature review. J Prev Alzheimers Dis. 2026 May; 13(5):100532.. View in PubMed
  • The burden of cognitive impairment. Alzheimers Dement. 2025 08; 21(8):e70436.. View in PubMed
  • Advancing the science of recruitment for Alzheimer’s clinical trials: Challenges and opportunities. J Prev Alzheimers Dis. 2025 Aug; 12(7):100230.. View in PubMed
  • Long-Term Health Improvements and Economic Performance Among Individuals With Diabetes. JAMA Health Forum. 2025 05 02; 6(5):e250756.. View in PubMed
  • Relation of income to trends in well-being by age: implications for the future older “forgotten” lower middle class. Health Aff Sch. 2025 Feb; 3(2):qxae183.. View in PubMed